Desmoid Clinical Trials

17 recruitingLast updated: May 29, 2026

There are 17 actively recruiting desmoid clinical trials across 16 countries. Studies span Phase 2, Not Applicable, Phase 1, Phase 4. Top locations include Palo Alto, California, United States, New York, New York, United States, Los Angeles, California, United States. Updated daily from ClinicalTrials.gov.


Desmoid Trials at a Glance

17 actively recruiting trials for desmoid are listed on ClinicalTrialsFinder across 6 cities in 16 countries. The largest study group is Phase 2 with 6 trials, with the heaviest enrollment activity in Palo Alto, New York, and Los Angeles. Lead sponsors running desmoid studies include Istituto Ortopedico Rizzoli, Children's Oncology Group, and Fondazione IRCCS Istituto Nazionale dei Tumori, Milano.

Browse desmoid trials by phase

Treatments under study

About Desmoid Clinical Trials

Looking for clinical trials for Desmoid? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Desmoid trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Desmoid clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 117 of 17 trials

Recruiting
Phase 1Phase 2

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Colorectal, CancerProstate CancerCancer+12 more
Parabilis Medicines, Inc.595 enrolled33 locationsNCT05919264
Recruiting

Observing People With Desmoid-Type Fibromatosis

Desmoid Fibromatosis
Memorial Sloan Kettering Cancer Center100 enrolled1 locationNCT04281381
Recruiting

Arterial Chemoembolization for the Treatment of Desmoid Fibromatosis

Desmoid
Istituto Ortopedico Rizzoli20 enrolled1 locationNCT06268457
Recruiting

Radiomics Compared With Conventional Response Criteria for Predicting Progression of Desmoid Tumor After Cryoablation

Desmoid
Istituto Ortopedico Rizzoli21 enrolled1 locationNCT06224283
Recruiting
Phase 4

Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)

Desmoid TumorAggressive Fibromatosis
SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany50 enrolled21 locationsNCT07176689
Recruiting
Phase 1Phase 2

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Ovarian CarcinomaColorectal CarcinomaMelanoma+19 more
Children's Oncology Group147 enrolled21 locationsNCT04851119
Recruiting

Project: Every Child for Younger Patients With Cancer

Malignant Solid NeoplasmNeuroendocrine NeoplasmCentral Nervous System Neoplasm+15 more
Children's Oncology Group75,000 enrolled278 locationsNCT02402244
Recruiting
Phase 2

A Study in Adults With Desmoid Tumors

Desmoid Tumor
Elpiscience (Suzhou) Biopharma, Ltd.50 enrolled1 locationNCT07541430
Recruiting

Immunological Phenotype of Desmoid-fibromatosis-affected Patients.

Desmoid-Type Fibromatosis
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano200 enrolled8 locationsNCT07496242
Recruiting
Phase 2

A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)

Desmoid TumorAggressive Fibromatosis
SpringWorks Therapeutics, Inc.18 enrolled3 locationsNCT07170644
Recruiting
Not Applicable

HIFU Ablation of Soft Tissue Sarcoma

Soft Tissue SarcomaDesmoid Tumors
Oxford University Hospitals NHS Trust10 enrolled1 locationNCT05111964
Recruiting

Electrochemotherapy for Desmoid Tumors

Desmoid Fibromatosis
Istituto Ortopedico Rizzoli30 enrolled1 locationNCT06660121
Recruiting
Not Applicable

Cryoablation Versus Medical Therapy in Desmoid Tumors Progressing After Watchful Waiting

Desmoid Tumor
University Hospital, Strasbourg, France150 enrolled13 locationsNCT06081400
Recruiting

Treatment of Desmoid Fibromatosis With Arterial Embolization

Desmoid Fibromatosis
Istituto Ortopedico Rizzoli20 enrolled1 locationNCT06945887
Recruiting
Phase 2

Study of Cryoablation and Nirogacestat for Desmoid Tumor

Desmoid Tumor
Nam Bui28 enrolled1 locationNCT05949099
Recruiting
Not Applicable

Cryotherapy in the Treatment of Desmoid Tumors

Desmoid
Istituto Ortopedico Rizzoli94 enrolled1 locationNCT05091255
Recruiting
Phase 2

Safety and Efficacy Study Using 5-ALA Oral Administration as an Adjuvant Therapy on the Rate of Local Tumor Recurrence in Patients Who Have Desmoids Tumors

Surgical ResectionThe Aim of the Study is to Evaluate the Efficacy of Photodynamic Therapy as anAdjuvant Therapy on the Clinical Outcome of Patients With Desmoid Tumors After
michal roll140 enrolled2 locationsNCT01898416